Alza, InterMune Pharmaceuticals Inc. deal

ITMN acquired worldwide exclusive rights to AZA’s Amphotec liposomal amphotericin

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE